May 19, 2014 | Keystone Heart, a medical device company and the developer of the TriGuard Cerebral Protection Device, has successfully raised $14 million in a Series B round of financing led by OrbiMed. OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, managing approximately $11 billion across public and private company investments.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments